150 related articles for article (PubMed ID: 37484058)
21. Plasma plasminogen activator inhibitor-1 predicts myocardial infarction in HIV-1-infected individuals.
Knudsen A; Katzenstein TL; Benfield T; Jørgensen NR; Kronborg G; Gerstoft J; Obel N; Kjær A; Lebech AM
AIDS; 2014 May; 28(8):1171-9. PubMed ID: 24566095
[TBL] [Abstract][Full Text] [Related]
22. Global REACH 2018: Influence of excessive erythrocytosis on coagulation and fibrinolytic factors in Andean highlanders.
DeSouza NM; Brewster LM; Bain AR; Garcia VP; Stone R; Stockelman KA; Greiner JJ; Tymko MM; Vizcardo-Galindo G; Figueroa-Mujica RJ; Villafuerte FC; Ainslie PN; DeSouza CA
Exp Physiol; 2021 Jun; 106(6):1335-1342. PubMed ID: 33745204
[TBL] [Abstract][Full Text] [Related]
23. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
24. Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Mori S
J Dermatol Sci; 1996 Mar; 11(3):223-7. PubMed ID: 8785174
[TBL] [Abstract][Full Text] [Related]
25. Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients.
Vucković BA; Djerić MJ; Ilić TA; Canak VB; Kojić-Damjanov SLj; Zarkov MG; Cabarkapa VS
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():12-7. PubMed ID: 20229676
[TBL] [Abstract][Full Text] [Related]
26. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19.
Al-Tamimi AO; Yusuf AM; Jayakumar MN; Ansari AW; Elhassan M; AbdulKarim F; Kannan M; Halwani R; Ahmad F
Int J Lab Hematol; 2022 Aug; 44(4):712-721. PubMed ID: 35266284
[TBL] [Abstract][Full Text] [Related]
28. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
29. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
[TBL] [Abstract][Full Text] [Related]
30. Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy.
Koppel K; Bratt G; Schulman S; Bylund H; Sandström E
J Acquir Immune Defic Syndr; 2002 Apr; 29(5):441-9. PubMed ID: 11981359
[TBL] [Abstract][Full Text] [Related]
31. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
Shinohara M; Kurokawa H; Yoshihara Y; Kokubu S; Kusano T; Horie K; Murakami N; Nagai K; Nara N
Rinsho Byori; 1997 Feb; 45(2):179-84. PubMed ID: 9121003
[TBL] [Abstract][Full Text] [Related]
32. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
[TBL] [Abstract][Full Text] [Related]
33. D-dimer as a Predictor of Altered Coagulation in HIV Patients in Nigeria.
Aisabokhale FA; Akingbola TS; Bamidele K
Niger J Physiol Sci; 2019 Jun; 34(1):99-105. PubMed ID: 31449278
[TBL] [Abstract][Full Text] [Related]
34. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
Wu WD; Xu YH; Tan PY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
[TBL] [Abstract][Full Text] [Related]
35. [Coagulation dysfunctions in patients with systemic inflammatory response syndrome].
Liu YG; Li CS
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):94-7. PubMed ID: 15059403
[TBL] [Abstract][Full Text] [Related]
36. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
37. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
38. Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.
Guzmán-Fulgencio M; Medrano J; Rallón N; Echeverria-Urabayen A; Miguel Benito J; Restrepo C; García-Álvarez M; Vispo E; San Roman J; Sánchez-Piedra C; Soriano V; Resino S
J Infect; 2011 Nov; 63(5):382-90. PubMed ID: 21855573
[TBL] [Abstract][Full Text] [Related]
39. Increased plasma fibrinolytic activity in bleeding gastrointestinal angiodysplasia.
Junquera F; Saperas E; Anglés A; Abadía C; Monasterio J; Malagelada JR
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):199-205. PubMed ID: 15674098
[TBL] [Abstract][Full Text] [Related]
40. Haptoglobin phenotypes with weak antioxidant capacity increase risk factors of cardiovascular disease in Ghanaian HIV-infected patients on highly active antiretroviral therapy.
Tagoe EA; Tagoe INA; Kuleape JA; Puplampu P; Amanquah S; Asare-Anane H; Quaye O
Trop Med Int Health; 2019 Jun; 24(6):766-774. PubMed ID: 30851231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
